Related Experiment Video
Updated: Jul 11, 2026
The Multifaceted Benefits of Protein Co-expression in Escherichia coli
Published on: February 5, 2015
High-level expression of functional tumor suppressor LKB1 in Escherichia coli
Jun'e Liu1, Tingmao Hu, Xin Hou
1College of Life Sciences, Inner Mongolia University, Hohhot 010021, China.
Abstract:
The human LKB1 tumor suppressor has been implicated as an important regulator of many cellular processes and signaling pathways, indicating that it could be a good candidate for anticancer drugs. The failure of its obtain high-level expression has been a major obstacle to study its protein structure and function in vitro. Here, we describe the high-level expression of human LKB1 in Escherichia coli and show its kinase activity and anticancer effects on a tumor cell line. The gene encoding LKB1 was optimized by replacing rare codons with codons frequently used in E. coli and synthesized with overlapping primers. The recombinant His-LKB1 was expressed in hosts BL21(DE3) (BL) and Rosetta-gami(DE3)pLysS (RG). His-LKB1 from BL was present mainly as inclusion body. The soluble His-LKB1 from RG accounted for 34.1% of total proteins and the yield of purified His-LKB1 was approximately 92 microg/ml. Purified His-LKB1 protein from both hosts was functionally active, as shown by reversible autophosphorylation and kinase activity in the absence of any other associated kinase. The growth inhibitory ratio of the purified BL-derived and RG-derived His-LKB1 on hepatic carcinoma SMMC-7721 cells was 24.97% and 45.68%, respectively, and both could produce significant cell-cycle arrest.
Insights
Researchers successfully expressed the human LKB1 tumor suppressor in E. coli, demonstrating its kinase activity and anticancer effects on liver cancer cells. This breakthrough facilitates further study of LKB1 for potential cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The human LKB1 tumor suppressor is crucial for cellular processes and signaling pathways.
- LKB1's potential as an anticancer drug target is hindered by difficulties in achieving high-level expression for structural and functional studies.
- Overcoming expression challenges is key to unlocking LKB1's therapeutic potential.
Purpose of the Study:
- To achieve high-level expression of human LKB1 in Escherichia coli (E. coli).
- To characterize the kinase activity of the expressed LKB1 protein.
- To evaluate the anticancer effects of LKB1 on a human tumor cell line.
Main Methods:
- Human LKB1 gene optimization using codon replacement and overlapping primer synthesis.
- Recombinant His-LKB1 expression in E. coli hosts BL21(DE3) and Rosetta-gami(DE3)pLysS.
- Purification of soluble His-LKB1 and assessment of kinase activity via autophosphorylation.
Main Results:
- Soluble His-LKB1 was successfully expressed in the Rosetta-gami host, yielding approximately 92 microg/ml.
- Purified His-LKB1 exhibited functional kinase activity, including reversible autophosphorylation.
- LKB1 demonstrated significant anticancer effects, inhibiting growth by 24.97% (BL-derived) and 45.68% (RG-derived) in SMMC-7721 liver cancer cells, inducing cell-cycle arrest.
Conclusions:
- High-level expression of functional human LKB1 in E. coli is achievable, particularly using the Rosetta-gami host.
- The expressed LKB1 possesses intrinsic kinase activity and potent anticancer effects on hepatic carcinoma cells.
- This study provides a foundation for further investigation of LKB1 as a therapeutic agent in cancer treatment.
Related Concept Videos
01:23Stringent Response in E. coli
02:23Abnormal Proliferation
01:25Inducible Operons: lac Operon
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:29Coordination of Gene Expression Processes in Bacteria